Finally, even though it would have been interesting to explore the possible metabolomic variations associated with the histological sub-types of IDH-mutant gliomas, we could not perform this analysis because we did not include sufficient oligodendrogliomas to be statistically relevant. This evidence concerns the gene IDH2 and central nervous system cancer.